SCHEMBL22417066

SCHEMBL22417066

CNNc1cccc(C(=N)NC(=O)OC(C)(C)C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 O15379 1/20 0.41
▸ HDAC1 Q13547 1/20 0.41
▸ HDAC2 Q92769 1/20 0.41
▸ HDAC8 Q9BY41 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ PRMT5 O14744 1/20 0.39
▸ WDR77 Q9BQA1 1/20 0.39
▸ KAT6A Q92794 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ LMNA P02545 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ CYP17A1 P05093 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ NAMPT P43490 1/20 0.35
▸ PPARG P37231 2/20 0.35
▸ PPARD Q03181 2/20 0.35
▸ PPARA Q07869 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16410203 0.82 SMN1; SMN2 (0.46) LMNAALDH1A1NPC1RAB9ACYP1A2
SCHEMBL3911487 0.81 NQO2 (0.47) KAT6AMAPTALDH1A1NPC1RAB9A
SCHEMBL7158402 0.78 PPARG (0.47) ALDH1A1NPC1RAB9APPARGPPARD
SCHEMBL23119695 0.77 HDAC3 (0.49) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL29952577 0.77 UNG (0.46) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL4503350 0.76 HDAC3 (0.60) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL3303912 0.75 RAB9A (0.45) NPSR1MAPTALDH1A1NPC1RAB9A
SCHEMBL30073948 0.74 NPC1 (0.52) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL23455420 0.74 NPC1 (0.52) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL16808314 0.73 ESR1 (0.41) HDAC1NPSR1LMNAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3113772-B1 TRIFLUOROMETHYL SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS BIOCRYST PHARM INC (US) 2020-09-09 — — EP disclosed
Send feedback